articleimg-1
Jan 19, 2021

Hungary negotiating delivery of one million doses of Sinopharm vaccine

A senior official at Hungary’s National Institute of Pharmacy and Nutrition (OGYÉI) has confirmed that the Chinese Sinopharm vaccine is being manufactured under safe conditions.

 

A senior official at Hungary’s National Institute of Pharmacy and Nutrition (OGYÉI) has confirmed that the Chinese Sinopharm vaccine is being manufactured under safe conditions.

Following an inspection on site, Ferenc Lukács, head of the authority’s inspection department, said the vaccine is being produced using cutting-edge technology in Beijing and under good conditions 

Meanwhile, Gergely Gulyás, Head of the Prime Minister’s Office, said Hungary had “practically reached an agreement” on a delivery of the Sinopharm vaccine. He added that the first shipment could be as large as one million doses, pending approval by Hungarian authorities.